Seeing Is Believing
with an average price target of $22.48. This is a potential upside of $0.93 (4.32%) from yesterday's end of day stock price of $21.55.
Fusion Pharmaceuticals 's activity chart (see below) currently has 12 price targets and 11 ratings on display.
Analysts average stock forecasts to be materialized ratio is 55.95% with an average time for these price targets to be met of 301.14 days.
Most recent stock forecast was given by GREGORY RENZA from RBC on 20-Mar-2024. First documented stock forecast 21-Jul-2020.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$16
$-5.55 (-25.75%)
$16
1 years 6 months 14 days ago
(20-Mar-2024)
1/2 (50%)
$-5.09 (-24.13%)
15
Hold
$13
$-8.55 (-39.68%)
$13
1 years 6 months 14 days ago
(20-Mar-2024)
3/4 (75%)
$-8.09 (-38.36%)
287
Hold
$11
$-10.55 (-48.96%)
$10
1 years 6 months 15 days ago
(19-Mar-2024)
1/2 (50%)
$-10.18 (-48.06%)
496
Buy
$13
$-8.55 (-39.68%)
$13
1 years 8 months 8 days ago
(26-Jan-2024)
2/3 (66.67%)
$2.11 (19.38%)
131
Buy
$16
$-5.55 (-25.75%)
$15
1 years 8 months 29 days ago
(05-Jan-2024)
4/4 (100%)
$7.65 (91.62%)
143
What is FUSN (Fusion Pharmaceuticals ) average time for price targets to be met?
Which analyst has the current highest performing score on FUSN (Fusion Pharmaceuticals ) with a proven track record?
Which analyst has the current lower performing score on FUSN (Fusion Pharmaceuticals ) with a proven track record?
Which analyst has the most public recommendations on FUSN (Fusion Pharmaceuticals )?
Which analyst is the currently most bullish on FUSN (Fusion Pharmaceuticals )?
Which analyst is the currently most reserved on FUSN (Fusion Pharmaceuticals )?